Evidence map›Paper›PMID 22528448›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2012

Ceramide and sphingosine-1-phosphate signaling in embryonic stem cell differentiation.

Erhard Bieberich

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Ceramide and S1P Signaling in Embryonic Stem Cell Differentiation.Methods in molecular biology (Clifton, N.J.) · 2018
    Article
  6. Article
  7. Sphingolipids in spinal cord injury.International journal of physiology, pathophysiology and pharmacology · 2016
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Erhard BieberichProgram in Developmental Neurobiology, Institute of Molecular Medicine and Genetics, Medical College of Georgia, Georgia Health Sciences University, Augusta, GA, USA. ebieberich@georgiahealth.edu
Augusta University · US

Funding

Function of ceramide in neurodegenerative diseaseR01AG034389 · NIA · UNIVERSITY OF KENTUCKY · PI BIEBERICH, ERHARD · 2010 to 2020
$3.6M
Regulation of neuronal stem cell deathR01NS046835 · NINDS · MEDICAL COLLEGE OF GEORGIA (MCG) · PI BIEBERICH, ERHARD · 2003 to 2006
$1.3M
NIA NIH HHS R01 AG034389NIA NIH HHS R01AG034389NINDS NIH HHS R01 NS046835NINDS NIH HHS R01NS046835
6 · The paper itself

Abstract

Recent studies show that bioactive lipids are important regulators for stem cell survival and differentiation. The sphingolipid ceramide and its derivative, sphingosine-1-phosphate (S1P), can act synergistically on embryonic stem (ES) cell differentiation. We show here simple methods to analyze sphingolipids in differentiating ES cells and to use ceramide and S1P analogs for the guided differentiation of mouse ES cells toward neuronal and glial lineage.

Indexed as

Cell DifferentiationSignal TransductionAnimalsCeramidesEmbryonic Stem CellsLysophospholipidsMiceSphingosineCeramidesLysophospholipidsSphingosinesphingosine 1-phosphate

Identifiers

PMID22528448
PMCPMC3724173
OpenAlexW2737238387

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.